ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,983Medicare Part D Prescriptions Filled, Including Refills

Rank: 34 out of 692

$1.31M Total Retail Price of All Prescriptions

Rank: 38 out of 692

611 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
38% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Louisiana
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 611 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

9% of this provider’s 611 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

38 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
LEVOTHYROXINE SODIUM 890 842 113 1 2
AMLODIPINE BESYLATE 784 715 119 2 1
OMEPRAZOLE 704 636 120 3 8
ATORVASTATIN CALCIUM 696 630 109 4 6
SIMVASTATIN 660 593 96 5 5
PRAVASTATIN SODIUM 605 550 98 6 10
METOPROLOL SUCCINATE 586 567 82 7 13
LISINOPRIL-HYDROCHLOROTHIAZIDE 436 393 67 8 38
LOSARTAN-HYDROCHLOROTHIAZIDE 406 394 54 9 45
NAMENDA 403 398* 40 10 29
CITALOPRAM HBR 333 308 51 11 26
GLIMEPIRIDE 327 295 46 12 30
FUROSEMIDE 319 276 66 13 7
DONEPEZIL HCL 316 311* 44 14 32
LOSARTAN POTASSIUM 314 293 44 15 19
FLUTICASONE PROPIONATE 301 273 113 16 39
METFORMIN HCL 286 265 49 17 9
VALSARTAN-HYDROCHLOROTHIAZIDE 281 269 39 18 63
SPIRONOLACTONE 274 243 45 19 82
METHYLPREDNISOLONE 272 249 183 20 92
HYDROCODONE-ACETAMINOPHEN 251 194 53 S3 21 3
HYDROCHLOROTHIAZIDE 249 222 41 22 11
CYMBALTA 244 197 30 23 41
WARFARIN SODIUM 231 226* 35 24 28
CARVEDILOL 230 202 37 25 21
LISINOPRIL 226 191 40 26 4
NEXIUM 218 194 39 27 18
POTASSIUM CHLORIDE 210 198 34 28 14
EVISTA 208 208 23 29 140
ADVAIR DISKUS 207 195 57 30 57
ALENDRONATE SODIUM 207 202* 35 30 40
ALLOPURINOL 198 177 34 32 36
MELOXICAM 198 193* 86 32 24
GABAPENTIN 194 162 40 34 12
VYTORIN 194 189* 33 34 199
METOPROLOL TARTRATE 192 166 32 36 16
BISOPROLOL-HYDROCHLOROTHIAZIDE 184 179* 22 37 164
CRESTOR 175 163 27 38 27
TORSEMIDE 169 164* 25 39 173
SYNTHROID 166 166 22 40 42
METFORMIN HCL ER 162 110 28 41 54
JANTOVEN 157 157 11 42 138
ESCITALOPRAM OXALATE 149 144* 32 43 33
TAMSULOSIN HCL 148 148 26 44 35
PIOGLITAZONE HCL 143 120 22 R 45 99
AMLODIPINE BESYLATE-BENAZEPRIL 140 129 23 46 48
FENOFIBRATE* 139 116 23 47 55
ATENOLOL 135 115 18 48 22
AZITHROMYCIN 135 122 104 48 51
SERTRALINE HCL 130 125* 23 50 31
JANUVIA 127 122* 14 51 59
ZETIA 123 108 20 52 83
TRAMADOL HCL 122 117* 38 53 20
POLYETHYLENE GLYCOL 3350 121 116* 27 54 69
EXELON 118 113* 17 55 112
DIGOX 116 116 19 56 88
SPIRONOLACTONE-HCTZ 115 115 21 57 298
LOVASTATIN 115 115 15 57 52
ZOLPIDEM TARTRATE 112 89 31 59 25
VITAMIN D2 112 112 13 59 236
CIPROFLOXACIN HCL 108 103* 76 61 64
ISOSORBIDE MONONITRATE ER 96 91* 13 62 66
AGGRENOX 96 78 11 62 158
CLOPIDOGREL 95 90* 16 64 17
CEFUROXIME 91 74 76 65 159
LANTUS 91 74 12 65 61
DIOVAN 90 78 14 67 34
PANTOPRAZOLE SODIUM 90 90 16 67 23
FENOFIBRATE* 89 84* 11 69 55
JANUMET 89 <11 <11 69 200
BENAZEPRIL HCL 87 82* 13 71 47
AMITIZA 84 79* 11 72 170
CYCLOBENZAPRINE HCL 83 60 12 R 73 90
MIRTAZAPINE 83 78* 12 73 76
ALPRAZOLAM 80 68 24 B 75 15
FINASTERIDE 79 79 18 76 97
AMITRIPTYLINE HCL 78 <11 <11 R 77 58
ROPINIROLE HCL 76 76 11 78 98
PREDNISONE 75 61 20 79 53
ONGLYZA 75 70* 13 79 149
AMOXICILLIN 74 69* 54 81 107
TRIAMTERENE-HCTZ 73 73 15 82 56
SUCRALFATE 72 67* 24 83 150
QUETIAPINE FUMARATE 71 71 12 A 84 50
LYRICA 70 <11 <11 85 70
PAROXETINE HCL 65 <11 <11 86 84
LORAZEPAM 65 60* 20 B 86 43
FENOFIBRATE* 64 37 11 88 55
MUPIROCIN* 63 58* 42 89 145
PIOGLITAZONE-METFORMIN 63 <11 <11 R 89 304
CELEBREX 62 <11 <11 91 87
DOXYCYCLINE HYCLATE 61 56* 35 92 109
ALFUZOSIN HCL 60 <11 <11 93 361
BENAZEPRIL-HYDROCHLOROTHIAZIDE 57 <11 <11 94 179
FENTANYL 57 <11 <11 S2 94 171
PROAIR HFA 56 51* 22 96 60
DILTIAZEM 24HR ER 55 <11 <11 97 123
OXYBUTYNIN CHLORIDE ER 55 55 11 97 136
BYSTOLIC 54 <11 <11 99 81
TRADJENTA 54 <11 <11 99 194
LOVAZA 53 <11 <11 101 128
LABETALOL HCL 53 <11 <11 101 160
HYDROXYCHLOROQUINE SULFATE 52 <11 <11 103 273
FLUOXETINE HCL 52 <11 <11 103 73
DIOVAN HCT 51 51 11 105 310
LANTUS SOLOSTAR 51 46* 12 105 78
DILTIAZEM ER 51 <11 <11 105 196
HUMALOG MIX 75-25 51 <11 <11 105 287
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 21, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.